ARCHIVES

Immunotherapy Shrinks Tumors In Phase I Study at St. Jude

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved Last Month By NCI’s CTEP

May 31, 2002

In Brief: Best Guess On NCI Director: Brown First Choice, Benacerraf Second; FDa On Saccharin

April 22, 1977

ASCO Members asked To Help In Planning

August 26, 1988

At Its Launch, STAR Trial Inherits Baggage Of Its Predecessor, P-1 Tamoxifin Study

June 4, 1999

Toxicology Program Seeks Comment On Substances.

March 23, 2001

NCI plans to cut staff access to The Cancer Letter; insiders allege attempt at “thought control.”

November 18, 2005